drugset / Trial / NCT00528970

A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair

NCT00528970

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the safety and efficacy of two different dose regimens (12 milligrams \[mg\] and 24 mg) of IV MOA-728 versus placebo in shortening the time to return of bowel function in participants receiving opioid analgesia administered via patient-controlled anesthesia (PCA), and who had undergone repair of large (greater than or equal to \[≥\]10 centimeters) ventral hernias with or without a mesh prosthesis via laparotomy or laparoscopy.

Timeline

Start
2007-10-17
Primary completion
2008-02-05
Completion
2008-02-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified 12 mg Intravenous
Subject Methylnaltrexone Other / unclassified 24 mg Intravenous

Indications